secwatch.observer — SEC 8-K summary
======================================

Issuer:     ProMIS Neurosciences Inc. (PMN)
CIK:        0001374339
Form:       8-K
Filed at:   2024-01-03T23:59:59+00:00
Accession:  0001558370-24-000021
Event type: leadership
Sentiment:  neutral
Materiality: 0.70
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ProMIS Neurosciences appoints Neil Warma as interim CEO after Gail Farfel departure
--------------------------------------------------------------------------------

- CEO Gail Farfel separated as President/CEO and Board member effective Dec 30, 2023; will receive severance per agreement.
- Neil Warma appointed interim CEO effective Dec 30, 2023; continues as Board member.
- Compensation: $250k base salary, up to $400k milestone bonus, and options for 200k shares.
- Warma brings neuroscience background; company plans to advance PMN310 in Alzheimer's and seek partnerships.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1374339/000155837024000021/0001558370-24-000021-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1374339/000155837024000021/pmn-20231230x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-24-000021

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer